Stephen Taub

Latest Articles

Said Nazem Haidar (Victor J. Blue/Bloomberg)

Haidar Surges 193 Percent in 2022

Stephen Taub January 18, 2023

Seongjoon Cho/Bloomberg

Averill Launches a New Fund

Stephen Taub January 17, 2023

Andreas Halvorsen (David Paul Morris/Bloomberg)

Viking Emerges Relatively Unscathed From a Bleak 2022

Stephen Taub January 12, 2023

Courtesy Photo

ValueAct Launches a New Japan Fund

Stephen Taub January 12, 2023

Glen Kacher (Victor J. Blue/Bloomberg)

It Was a Tough Year to Be a Tiger

Stephen Taub January 11, 2023

David Paul Morris/Bloomberg

What Drove Third Point’s Disastrous Year

Stephen Taub January 10, 2023

Larry Robbins (Alex Flynn/Bloomberg)

Glenview Posts Mixed Results in 2022

Stephen Taub January 9, 2023

Ken Griffin (Christopher Dilts/Bloomberg)

Citadel Posts Its Biggest Gain in Over a Decade

Stephen Taub January 6, 2023

(Courtesy Photo)

Steve Cohen Made More Than $1.7 Billion in 2022

Stephen Taub January 5, 2023

Greg Jensen (Simon Dawson/Bloomberg)

Bridgewater Rebounds in December

Stephen Taub January 4, 2023

Illustration by II

Hedge Fund Favorites Limp to the Finish Line

Stephen Taub January 3, 2023

David Einhorn (Andrew Harrer/Bloomberg)

Greenlight Ends 2022 on a High Note

Stephen Taub January 3, 2023

David Einhorn (Andrew Harrer/Bloomberg)

Greenlight Ends 2022 on a High Note

Stephen Taub January 3, 2023

Carsten Snejbjerg/Bloomberg

Biopharma Funds Are Still Embracing VC

Stephen Taub December 21, 2022

Illustration by II

Tech Funds Shun VC Investments

Stephen Taub December 20, 2022

Illustration by II

JW Asset Management Has a Sobering Year

Stephen Taub December 19, 2022

Amir Hamja/Bloomberg

It’s Been a Bad Year for IPOs — But Hedge Funds Are Betting on These New Offerings

Stephen Taub December 16, 2022

(Lauryn Ishak/Bloomberg)

The Prognosis Brightens for Biopharma Funds

Stephen Taub December 14, 2022

Contact Info

New York
1270 Avenue of the Americas, Suite 1100
New York, NY 10020
P: +1 212 224 3300

London
4 Bouverie Street
London EC4Y 8AX
P: +44 207 779 8888

Hong Kong
Unit 2488, 24/F
Lee Garden One,
33 Hysan Avenue
Causeway Bay, Hong Kong
P: +852 2912 8001

Corporate

About Us

Leadership Team

Careers

II Press Room

Digital

Masthead

Thought Leadership

Display Advertising

Reprints

FAQs

Events

Events Calendar

Memberships

Subscription

Subscribe to Premium

Register

Register for Free Account

Newsletters

Sign up for II newsletters

© 2025 Institutional Investor LLC. All material subject to strictly enforced copyright laws. Please read our Terms & Conditions, Modern Slavery Act Transparency Statement, Accessibility Statement and Privacy Policy before using the site.

release/4.13.00 build:2025-12-17 Login